183 related articles for article (PubMed ID: 8345544)
1. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
Edrissian GH; Afshar A; Sayedzadeh A; Mohsseni G; Satvat MT
J Trop Med Hyg; 1993 Aug; 96(4):237-40. PubMed ID: 8345544
[TBL] [Abstract][Full Text] [Related]
2. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
Djaman J; Abouanou S; Basco L; Koné M
Sante; 2004; 14(4):205-9. PubMed ID: 15745869
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Del Nero L; Lamizana L; Pietra V; Nebié I
Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Ghosh SK; Yadav RS; Sharma VP
Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
[TBL] [Abstract][Full Text] [Related]
5. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.
al-Yaman F; Genton B; Mokela D; Narara A; Raiko A; Alpers MP
P N G Med J; 1996 Mar; 39(1):16-22. PubMed ID: 9522846
[TBL] [Abstract][Full Text] [Related]
6. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
Garg MR; Gogtay NJ; Kshirsagar NA
J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
Adagu SI; Okoyeh JN; Lege-Oguntoye L; Ogala WN; Ogunrinde GO; Faji JT; Sani AH
J Trop Med Hyg; 1995 Oct; 98(5):296-8. PubMed ID: 7563254
[TBL] [Abstract][Full Text] [Related]
9. Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania.
Irare SG; Lemnge MM; Mhina JI
Trop Geogr Med; 1991 Oct; 43(4):352-6. PubMed ID: 1812599
[TBL] [Abstract][Full Text] [Related]
10. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
Kamugisha J; Kipp W; Burnham G
Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
[TBL] [Abstract][Full Text] [Related]
11. Imported cases of chloroquine-resistant falciparum malaria in Iran.
Edrissian GH; Shahabi S; Pishva E; Hajseyed-Javadi J; Khaleghian B; Ghorbani M; Emadi AM; Afshar A; Saghari H
Bull Soc Pathol Exot Filiales; 1986; 79(2):217-21. PubMed ID: 3524879
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
Huang OL; Ouyang WC; Zhou JX; Wu Z; Zhang KY; Huang JK; Cai XZ; Pang XJ; Fu SG; Wang XF
Bull World Health Organ; 1988; 66(3):353-8. PubMed ID: 3048759
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
Del Nero L; Nebie I; Soudouem G; Pietra V
Trop Geogr Med; 1994; 46(1):8-10. PubMed ID: 8165742
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Plasmodium falciparum to pyrimethamine in vivo and to sulphadoxine/pyrimethamine combination in vitro in pregnant women of northern Nigeria.
Okoyeh JN; Lege-Oguntoye L; Emembolu JO; Sarki U; Slotboom AB
J Trop Med Hyg; 1993 Feb; 96(1):56-9. PubMed ID: 8429576
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
[TBL] [Abstract][Full Text] [Related]
17. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
Dinis DV; Schapira A
Bull Soc Pathol Exot; 1990; 83(4):521-7; discussion 528. PubMed ID: 2286005
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum sensitivity to antimalarials at Humera, northwestern Ethiopia.
Wezam A
Ethiop Med J; 1993 Oct; 31(4):271-6. PubMed ID: 8287862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
